MZ
Therapeutic Areas
BioLineRx Pipeline
| Drug | Indication | Phase |
|---|---|---|
| APHEXDA® (motixafortide/BL-8040) | Stem Cell Mobilization for Autologous Transplantation in Multiple Myeloma | Approved |
| motixafortide (BL-8040) | Metastatic Pancreatic Adenocarcinoma | Phase 2b |
| AGI-134 | Solid Tumors | Phase 1/2a |
| BL-1210 / BL-1230 | Gastroenterology / Immunology | Pre-clinical |
Leadership Team at BioLineRx
PS
Philip Serlin
Chief Executive Officer and Chief Financial Officer
ES
Ella Sorani
Chief Development & Operations Officer
SS
Stephen Squinto
Executive Chair of the Board of Directors
MJ
Michael J. Wyzga
Director
JA
Jack A. Khattar
Director
MK
Marlene Krauss
Director
RS
Rami Skaliter
Director
AB
Amos Bar-Shalev
Director